Clinical Trial Update: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight [Phase 3]

View source ↗

Summary

Phase 3 trial update for CagriSema in obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING